Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The document concludes that more research is needed to fully understand the causes of PCOS.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

The document concludes that in Sri Lanka, 25 common plants are traditionally used as home remedies for various health issues due to their medicinal properties.

Ayurvedic treatment improved PCOS symptoms in a 40-year-old woman.

Finasteride doesn't affect ovulation in normal women.

Ayurvedic treatment and Yoga Basti therapy improved a woman's PCOS symptoms.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.